Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant

By Isaka M.   Yasuda Y.   Taniguchi T.   Kozuka S.   Matano K.   Maeyama J.-i.   Morokuma K.   Ohkuma K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1165-1173

Elsevier

Access to resources Recommend Favorite

Modulation of mucosal and systemic immunity by intranasal interleukin 12 delivery

By Arulanandam B.P.   Metzger D.W.  

Vaccine, Vol. 17, Iss. 3, 1999-02 ,pp. : 252-260

Elsevier

Access to resources Recommend Favorite

RGD motif enhances immunogenicity and adjuvanicity of peptide antigens following intranasal immunization

By Yano A.   Onozuka A.   Matin K.   Imai S.   Hanada N.   Nisizawa T.  

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 237-243

Elsevier

Access to resources Recommend Favorite

Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration

By Eyles J.E.   Bramwell V.W.   Williamson E.D.   Alpar H.O.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4732-4742

Elsevier

Access to resources Recommend Favorite

Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses

By Debin A.   Kravtzoff R.   Santiago J.V.   Cazales L.   Sperandio S.   Melber K.   Janowicz Z.   Betbeder D.   Moynier M.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2752-2763

Elsevier

Access to resources Recommend Favorite